A Democratic bill with 1 Republican cosponsor · See the cosponsor
Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The "Stop Superbugs Act" directs the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant to the Antibiotic Resistance Leadership Group. This grant is intended to facilitate a clinical research network focused on antibiotic resistance. The network will focus on several specific areas including participant recruitment and clinical trial outreach. It also aims to pair diagnostic and pharmaceutical innovations and develop patient-reported outcomes. The bill authorizes necessary appropriations to carry out these goals.
Yes
- Scored +6
Does this put more money into medical research?
The bill authorizes funding specifically for a clinical research network to combat antibiotic resistance.
- Scored +5
Does this put more money into scientific research?
The bill provides authorization for funding to advance scientific research in antibiotic resistance.
- Scored +1
Does this make health care easier to get in general?
The bill aims to improve clinical research and treatment innovations for antibiotic resistance.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved Clinical Research Participation: The bill focuses on supporting rapid recruitment of participants and conducting outreach in community settings, which can help move research forward (Section 2(a)(1) and Section 2(a)(2)).
-
Enhanced Medical Innovations: The research network aims to pair diagnostic and pharmaceutical innovations during clinical trials, which could lead to better treatment tools (Section 2(a)(3)).
-
Focus on Patient Experience: By developing patient-reported outcomes in clinical studies, the research can better account for the actual experiences of patients (Section 2(a)(4)).
Potential Negative Impacts for People
- No negative impacts are explicitly mentioned in the text provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this put more money into medical research? — The bill authorizes funding specifically for a clinical research network to combat antibiotic resistance. Does this make health care easier to get in general? — The bill aims to improve clinical research and treatment innovations for antibiotic resistance.
- Education And Technology
- Does this put more money into scientific research? — The bill provides authorization for funding to advance scientific research in antibiotic resistance.
- 8/4/2026
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 1 Cosponsor added.
- Introduced in Senate
Roger MarshallRepublican · Kansas